stockportfolio.pro
Stocks / KMDA vs OCGN
KMDA vs OCGN
Kamada Ltd. and Ocugen, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Kamada Ltd. (KMDA) | Ocugen, Inc. (OCGN) | |
|---|---|---|
| Market cap | $0.4B | $0.4B |
| Revenue (latest FY) | $180.46M | $4.41M |
| Net income (latest FY) | $20.20M | $-67.85M |
| Revenue growth (5y CAGR) | 11.7% | 152.5% |
| Net margin | 11.2% | -1537.4% |
| Return on equity | 7.5% | 557.7% |
| P/E ratio | 20.9 | — |
| Dividend yield | 3.5% | — |
| Profitable years (of last 10) | 3 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open KMDA — free Open OCGN — freeFrequently asked questions
Which is bigger, KMDA or OCGN?
Kamada Ltd. is larger by market capitalization — $0.4B versus $0.4B.
Which grows faster, KMDA or OCGN?
Over the last five fiscal years, Ocugen, Inc. grew revenue faster — 152.5%/yr versus 11.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.